Page 96 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis

Chapter 4
References
1. Akbari-Birgani S, Paranjothy T, Zuse A, Janikowski T, Cieslar-Pobuda A, Likus W, et al. Cancer stem cells, cancer-initiating cells and methods for their detection. Drug Discov Today. 2016;21(5):836-42.
2. Moreira ML, da Costa Medeiros P, de Souza SA, Gutfilen B, Rosado-de-Castro PH. In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine. Stem Cells Int. 2016;2016:3140120.
3. Bernsen MR, Kooiman K, Segbers M, van Leeuwen FW, de Jong M. Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging. 2015;42(4):579-96.
4. Accomasso L, Gallina C, Turinetto V, Giachino C. Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview. Stem Cells Int. 2016;2016:7920358.
5. Liu Z, Li Z. Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs). Theranostics. 2014;4(10):990-1001.
6. Hong H, Yang Y, Zhang Y, Cai W. Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem. 2010;10(12):1237-48.
7. Gimi B, Mori N, Ackerstaff E, Frost EE, Bulte JW, Bhujwalla ZM. Noninvasive MRI of endothelial cell response to human breast cancer cells. Neoplasia. 2006;8(3):207-13.
8. Xiong L, Cao F, Cao X, Guo Y, Zhang Y, Cai X. Long-term-stable near-infrared polymer dots with ultrasmall size and narrow-band emission for imaging tumor vasculature in vivo. Bioconjug Chem. 2015;26(5):817-21.
9. Ramaswamy S, Schornack PA, Smelko AG, Boronyak SM, Ivanova J, Mayer JE, Jr., et al. Superparamagnetic iron oxide (SPIO) labeling efficiency and subsequent MRI tracking of native cell populations pertinent to pulmonary heart valve tissue engineering studies. NMR Biomed. 2012;25(3):410-7.
10. Fayol D, Le Visage C, Ino J, Gazeau F, Letourneur D, Wilhelm C. Design of biomimetic vascular grafts with magnetic endothelial patterning. Cell Transplant. 2013;22(11):2105-18.
11. Fu Y, Azene N, Xu Y, Kraitchman DL. Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques. Imaging Med. 2011;3(4):473-86.
12. Youn H, Hong KJ. In vivo non invasive molecular imaging for immune cell tracking in small animals. Immune Netw. 2012;12(6):223-9.
13. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med. 2006;55(2):242-9.
14. Lee N, Kim H, Choi SH, Park M, Kim D, Kim HC, et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc Natl Acad Sci USA. 2011;108(7):2662-7.
15. Ngen EJ, Artemov D. Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives. Int J Mol Sci. 2017;18(1).
16. Zhang Z, van den Bos EJ, Wielopolski PA, de Jong-Popijus M, Bernsen MR, Duncker DJ, et al. In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA. 2005;18(4):175-85.
17. Gamarra LF, Brito GES, Pontuschka WM, Amaro E, Parma AHC, Goya GF. Biocompatible superparamagnetic iron oxide nanoparticles used for contrast agents: a structural and magnetic study. J Magn Magn Mater. 2005;289(0):439-41.
18. Neuwelt A, Sidhu N, Hu CA, Mlady G, Eberhardt SC, Sillerud LO. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am J Roentgenol. 2015;204(3):W302-13.
19. Bernsen MR, Guenoun J, Van Tiel ST, Krestin GP. Nanoparticles and clinically applicable cell tracking. Brit J Radiol. 2015;88(1054).
20. Reddy LH. Drug delivery to tumours: recent strategies. J Pharm Pharmacol. 2005;57(10):1231-42.
21. Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112(11):5818-78.
94